Agios Pharmaceuticals (AGIO) Other Accumulated Expenses (2012 - 2017)
Agios Pharmaceuticals (AGIO) posted Other Accumulated Expenses of $1.3 million for Q1 2017, up 670.83% on a QoQ basis from $168000.0 in Q4 2016, and up 386.84% year-over-year from $266000.0 in Q1 2016.
Agios Pharmaceuticals (AGIO) Other Accumulated Expenses (2012 - 2017) Analysis & Trends
Agios Pharmaceuticals' Other Accumulated Expenses history runs 6 years deep, the most recent figure standing at $1.3 million for Q1 2017.
- Quarterly Other Accumulated Expenses rose 386.84% year-over-year to $1.3 million in Q1 2017, while the trailing twelve-month figure through Mar 2017 was $1.3 million (up 386.84% YoY) and the FY2016 annual result came in at $168000.0, down 87.21% from the prior year.
- Other Accumulated Expenses was $1.3 million for Q1 2017 at Agios Pharmaceuticals, up from $168000.0 in the prior quarter.
- Across five years, Other Accumulated Expenses topped out at $1.3 million in Q4 2015 and bottomed at $4000.0 in Q1 2015.
- A 5-year average of $504687.5 and a median of $420500.0 in 2013 frame the typical range for Other Accumulated Expenses.
- Annual changes were most pronounced in 2015 — Other Accumulated Expenses slumped 99.36% — and 2016, when it jumped 6550.0%.
- Agios Pharmaceuticals' Other Accumulated Expenses stood at $140000.0 in 2013, then surged by 215.71% to $442000.0 in 2014, then surged by 197.29% to $1.3 million in 2015, then sank by 87.21% to $168000.0 in 2016, then soared by 670.83% to $1.3 million in 2017.
- Business Quant data shows AGIO's Other Accumulated Expenses at $1.3 million in Q1 2017, $168000.0 in Q4 2016, and $538000.0 in Q3 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Agios Pharmaceuticals | 2.13 Bn | 2.13 Bn | 19.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2017 | 1.30 Mn |
| Dec 31, 2016 | 168,000.00 |
| Sep 30, 2016 | 538,000.00 |
| Jun 30, 2016 | 207,000.00 |
| Mar 31, 2016 | 266,000.00 |
| Dec 31, 2015 | 1.31 Mn |
| Sep 30, 2015 | 356,000.00 |
| Jun 30, 2015 | 752,000.00 |
| Mar 31, 2015 | 4,000.00 |
| Dec 31, 2014 | 442,000.00 |
| Sep 30, 2014 | 1.04 Mn |
| Jun 30, 2014 | 93,000.00 |
| Mar 31, 2014 | 624,000.00 |
| Dec 31, 2013 | 140,000.00 |
| Sep 30, 2013 | 426,000.00 |
| Jun 30, 2013 | 415,000.00 |
| Dec 31, 2012 | 65,000.00 |